StocksFundsScreenerSectorsWatchlists
PRGO

PRGO - Perrigo Co PLC Stock Price, Fair Value and News

30.56USD+0.62 (+2.07%)Delayed as of 19 Apr 2024, 01:11 pm ET

Market Summary

PRGO
USD30.56+0.62
Delayedas of 19 Apr 2024, 01:11 pm
2.07%

PRGO Stock Price

View Fullscreen

PRGO RSI Chart

PRGO Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

-319.48

Price/Sales (Trailing)

0.87

EV/EBITDA

39.13

Price/Free Cashflow

13.36

PRGO Price/Sales (Trailing)

PRGO Profitability

EBT Margin

-0.18%

Return on Equity

-0.27%

Return on Assets

-0.12%

Free Cashflow Yield

7.49%

PRGO Fundamentals

PRGO Revenue

Revenue (TTM)

4.7B

Rev. Growth (Yr)

0.15%

Rev. Growth (Qtr)

2.95%

PRGO Earnings

Earnings (TTM)

-12.7M

Earnings Growth (Yr)

-36.29%

Earnings Growth (Qtr)

-327.46%

Breaking Down PRGO Revenue

52 Week Range

29.8240.28
(Low)(High)

Last 7 days

-4.2%

Last 30 days

-1.0%

Last 90 days

-9.5%

Trailing 12 Months

-17.3%

How does PRGO drawdown profile look like?

PRGO Financial Health

Current Ratio

1.79

Debt/Equity

0.76

Debt/Cashflow

0.11

PRGO Investor Care

Dividend Yield

3.64%

Dividend/Share (TTM)

1.09

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-0.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20234.6B4.6B4.7B4.7B
20224.2B4.3B4.4B4.5B
20214.3B4.3B4.3B4.1B
20204.7B4.5B4.4B4.3B
20194.7B4.7B4.7B4.8B
20185.0B4.9B4.8B4.7B
20175.1B5.0B5.0B4.9B
20165.4B5.3B5.3B5.3B
20154.0B4.2B4.6B5.0B
20143.9B4.1B4.0B4.0B
20133.4B3.5B3.7B3.8B
201203.2B3.3B3.4B

Tracking the Latest Insider Buys and Sells of Perrigo Co PLC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 07, 2024
janish ronald craig
acquired
87,348
29.69
2,942
evp, gbl ops & sc & cto
Mar 07, 2024
willis robert
sold (taxes)
-33,401
29.69
-1,125
evp & chro
Mar 07, 2024
ives alison
sold (taxes)
-15,616
29.69
-526
evp & chief scientific officer
Mar 07, 2024
janish ronald craig
sold (taxes)
-26,305
29.69
-886
evp, gbl ops & sc & cto
Mar 07, 2024
ives alison
acquired
51,838
29.69
1,746
evp & chief scientific officer
Mar 07, 2024
quinn grainne
sold (taxes)
-34,737
29.69
-1,170
evp, chief medical officer
Mar 07, 2024
quinn grainne
acquired
66,772
29.69
2,249
evp, chief medical officer
Mar 07, 2024
andersen svend
acquired
162,345
29.69
5,468
evp & president chci
Mar 07, 2024
willis robert
acquired
64,219
29.69
2,163
evp & chro
Mar 06, 2024
janish ronald craig
sold (taxes)
-19,466
28.09
-693
evp, gbl ops & sc & cto

1–10 of 50

Which funds bought or sold PRGO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 17, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD
unchanged
-
172,000
1,057,000
0.04%
Apr 16, 2024
Financial Management Professionals, Inc.
unchanged
-
-
76,000
0.01%
Apr 16, 2024
Pinnacle Bancorp, Inc.
added
84.56
4,057
8,852
-%
Apr 16, 2024
VOISARD ASSET MANAGEMENT GROUP, INC.
unchanged
-
8.00
24,143
0.01%
Apr 16, 2024
Perpetual Ltd
added
20.45
13,194,500
87,489,800
0.86%
Apr 16, 2024
Asset Dedication, LLC
unchanged
-
-
5,000
-%
Apr 15, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
reduced
-1.37
-4,971
365,324
-%
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
added
35.56
188,251
716,968
0.02%
Apr 15, 2024
Legato Capital Management LLC
added
18.74
96,666
611,449
0.07%
Apr 12, 2024
HARBOR INVESTMENT ADVISORY, LLC
added
460
1,481
1,803
-%

1–10 of 47

Are Funds Buying or Selling PRGO?

Are funds buying PRGO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PRGO
No. of Funds

Unveiling Perrigo Co PLC's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
barrow hanley mewhinney & strauss llc
12.%
10
SC 13G
Feb 13, 2024
vanguard group inc
11.07%
14,994,309
SC 13G/A
Jan 24, 2024
blackrock inc.
9.8%
13,342,622
SC 13G/A
Feb 15, 2023
barrow hanley mewhinney & strauss llc
7.30%
9,825,539
SC 13G
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.1%
78,305
SC 13G/A
Feb 09, 2023
vanguard group inc
10.84%
14,590,276
SC 13G/A
Jan 24, 2023
blackrock inc.
9.8%
13,221,594
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
8.0%
10,721,574
SC 13G/A
Feb 03, 2022
blackrock inc.
8.6%
11,557,239
SC 13G/A

Recent SEC filings of Perrigo Co PLC

View All Filings
Date Filed Form Type Document
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading
Apr 09, 2024
4
Insider Trading

Peers (Alternatives to Perrigo Co PLC)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
351.1B
85.2B
-6.70% -10.33%
9.99
4.12
6.46% 95.94%
317.1B
60.1B
2.45% 9.70%
868.73
5.27
1.40% -97.49%
143.3B
46.5B
-8.14% -36.93%
-103.22
3.08
42.59% -114.62%
140.8B
28.2B
-3.32% 6.70%
20.96
4.99
7.09% 2.52%
82.4B
27.1B
-9.93% -21.39%
14.54
3.04
-0.60% 23.36%
14.3B
15.8B
-4.27% 50.53%
-24.85
0.9
6.17% 76.47%
MID-CAP
4.1B
4.7B
-0.96% -17.31%
-319.48
0.87
4.58% 90.97%
4.0B
1.7B
-14.12% -18.81%
11.16
2.39
49.61% 324.78%
3.1B
8.8B
-9.85% 14.21%
-5.31
0.36
7.79% -163.11%
1.9B
644.4M
-13.30% -10.60%
13.51
2.88
29.14% 50.51%
SMALL-CAP
1.3B
743.2M
-9.90% -28.22%
-3.8
1.8
24.65% 80.36%
21.7M
1.3M
-17.90% -49.05%
-2.11
16.65
-98.14% -109.18%
17.6M
-
-9.57% 32.48%
-0.96
0.22
2882.68% -138.52%
2.5M
19.6M
-30.19% -94.45%
-0.18
0.13
80.00% 43.08%
472.0K
117.6M
-96.45% -95.94%
0
0
-0.79% -283.60%

Perrigo Co PLC News

Latest updates
MarketWatch20 hours ago
Yahoo Finance15 Apr 202412:15 pm

Perrigo Co PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue2.9%1,1571,1241,1931,1821,1551,1001,1221,0751,1051,0439811,0101,2901,0039491,0831,3231,1911,1491,1751,195
Gross Profit3.9%427411428414383363372338362336349368469370347394481413431449443
Operating Expenses26.9%443349371365352330379316316-101475317347291285307178358376347336
  S&GA Expenses1.6%153150171168154145151136131130140136157130119140116134140149145
  R&D Expenses0%30.0030.0032.0031.0033.0030.0032.0029.0030.0028.0033.0031.0033.0030.0030.0028.00-8.8544.0044.0040.0045.00
EBITDA Margin-0.04*-0.11*0.11*0.11*0.10*0.10*0.11*0.12*0.12*0.12*0.13*0.13*--------
Interest Expenses2.0%-42.65-43.50-44.00-43.70-40.90-41.00-38.30-35.80-30.50-30.90-31.60-32.00-33.35-33.30-32.20-28.90-27.15-30.50-31.20-28.60-32.80
Income Taxes-801.3%-26.654.0014.005.00-1.6549.00-43.40-11.70-22.20443-45.2014.00-63.2022.003.00-0.20-50.805.0018.0017.00122
EBT Margin-Infinity%0.00*-0.06*0.06*0.07*0.07*0.07*0.07*0.07*0.07*0.07*0.07*0.07*--------
Net Income-327.5%-32.3014.008.00-3.00-23.70-49.40-65.10-2.4010.00-58.90-57.7038.00-175-15461.00106-19.0092.009.0064.0082.00
Net Income Margin-209.6%0.00*0.00*-0.01*-0.03*-0.03*-0.02*-0.03*-0.03*-0.02*-0.06*-0.08*-0.05*---------
Free Cashflow96.3%18293.0033.00-3.8016038.00-45.3059.00-147302-105-45.20---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets0.5%10,80910,75810,96510,95511,01710,67810,92010,39010,42610,91611,23011,32511,48811,57612,12811,40111,30111,31111,42911,12010,983
  Current Assets2.4%2,8332,7652,7732,7412,7202,5832,6523,9363,8604,2264,4204,4893,1343,3983,8043,0462,7312,7403,4353,0092,902
    Cash Equivalents25.6%7515985555536014694851,9661,8652,0783184716328401,4384923453991,056838542
  Inventory-0.7%1,1411,1501,1681,1831,1501,0851,0801,0221,0201,0931,1161,1361,0591,1011,035931967991941913878
  Net PPE1.5%916903918919926840840846864843834860865919892889774871824821829
Liabilities0.3%6,0416,0206,1166,1216,1756,0756,0705,2855,2745,7345,7195,7675,8335,7566,2175,6145,4975,5525,7025,4195,315
  Current Liabilities57.3%1,5861,0081,0571,0871,1141,0151,0159811,5882,0041,9851,4471,3821,3361,8601,6351,3361,3251,7911,8321,537
  Long Term Debt-10.3%3,6334,0494,0564,0634,0704,0784,0863,5112,9172,9212,9263,5253,5283,5443,5363,1833,3663,3623,0842,7503,052
    LT Debt, Current1056.4%44138.0038.0039.0036.0034.0031.005.0060462963036.0037.0017.006072883.003.00399468190
    LT Debt, Non Current-10.3%3,6334,0494,0564,0634,0704,0784,0863,5112,9172,9212,9263,5253,5283,5443,5363,1833,3663,3623,0842,7503,052
Shareholder's Equity0.6%4,7684,7384,8494,8344,8424,6034,8505,1055,1525,1825,5115,5585,6555,8205,9105,7865,8045,7595,7265,7015,668
  Retained Earnings-1.6%-2,080-2,048-2,062-2,070-2,067-2,043-1,994-1,929-1,927-1,936-1,877-1,820-1,858-1,683-1,528-1,589-1,695-1,676-1,768-1,777-1,838
Shares Outstanding0%136136135135135135135134134134133133---------
Minority Interest--------------0.001.001.000.000.000.000.000.00
Float---4,596---5,521---6,266---7,361---6,477--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations67.6%20912553.0019.0018659.00-16.9079.00-105344-82.300.0011063.0029117290.0014064.0095.00194
  Share Based Compensation-27.9%11.0015.0019.0025.008.009.0011.0026.0010.0011.0014.0025.0015.0014.0014.0016.0011.0013.0016.0012.0011.00
Cashflow From Investing25.7%-22.80-30.70-4.40-19.60-26.00-20.90-1,97463.00-41.901,454-21.80-114-127-38.6053.00-74.80-106-651-68.10230-46.10
Cashflow From Financing-3.0%-44.60-43.30-48.60-50.70-42.50-43.00559-51.90-58.00-36.30-41.10-43.30-201-64660265.00-31.50-144220-41.60-34.30
  Dividend Payments-3.3%38.0039.0037.0036.0035.0037.0035.0034.0032.0033.0033.0033.0031.0031.0031.0031.0029.0029.0029.0026.0026.00
  Buy Backs--------------1.00-------

PRGO Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 4,655.6$ 4,451.6$ 4,138.7
Cost of sales2,975.22,996.22,722.5
Gross profit1,680.41,455.41,416.2
Operating expenses   
Distribution110.5113.093.0
Research and development122.5123.1122.0
Selling641.8584.8536.4
Administration522.3512.3482.0
Impairment charges90.00.0173.1
Restructuring42.242.516.9
Other operating (income) expense, net(0.8)0.8(417.6)
Total operating expenses1,528.51,376.51,005.8
Operating income151.978.9410.4
Interest Expense, net173.8156.0125.0
Other (income) expense, net(10.4)53.126.7
(Gain) loss on extinguishment of debt(3.2)8.90.0
Income (loss) from continuing operations before income taxes(8.3)(139.1)258.7
Income tax (benefit) expense(3.9)(8.2)389.6
Income (loss) from continuing operations(4.4)(130.9)(130.9)
Income (loss) from discontinued operations, net of tax(8.3)(9.7)62.0
Net income (loss)$ (12.7)$ (140.6)$ (68.9)
Basic   
Continuing operations (in dollars per share)$ (0.03)$ (0.97)$ (0.98)
Discontinued operations (in dollars per share)(0.06)(0.07)0.46
Basic (in dollars per share)(0.09)(1.04)(0.52)
Diluted   
Continuing operations (in dollars per share)(0.03)(0.97)(0.98)
Discontinued operations (in dollars per share)(0.06)(0.07)0.46
Diluted (in dollars per share)$ (0.09)$ (1.04)$ (0.52)
Weighted-average shares outstanding   
Basic (in shares)135.3134.5133.6
Diluted (in shares)135.3134.5133.6

PRGO Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets  
Cash, cash equivalents and restricted cash$ 751.3$ 600.7
Accounts receivable, net of allowance for credit losses of $7.8 and $6.8, respectively739.6697.1
Inventories1,140.91,150.3
Prepaid expenses and other current assets201.1271.8
Total current assets2,832.92,719.9
Property, plant and equipment, net916.4926.3
Operating lease assets183.6217.1
Goodwill and indefinite-lived intangible assets3,534.43,549.0
Definite-lived intangible assets, net2,980.83,230.2
Deferred income taxes25.87.1
Other non-current assets335.2367.7
Total non-current assets7,976.28,297.4
Total assets10,809.111,017.3
Liabilities and Shareholders’ Equity  
Accounts payable477.7537.3
Payroll and related taxes127.0136.4
Accrued customer programs163.5139.1
Other accrued liabilities335.4250.2
Accrued income taxes42.114.4
Current indebtedness440.636.2
Total current liabilities1,586.31,113.6
Long-term debt, less current portion3,632.84,070.4
Deferred income taxes262.3368.2
Other non-current liabilities559.8623.0
Total non-current liabilities4,454.95,061.6
Total liabilities6,041.26,175.2
Contingencies - Refer to Note 19
Controlling interests:  
Preferred shares, $0.0001 par value per share, 10 shares authorized0.00.0
Ordinary shares, €0.001 par value per share, 10,000 shares authorized6,837.56,936.7
Accumulated other comprehensive income10.7(27.0)
Retained earnings (accumulated deficit)(2,080.3)(2,067.6)
Total shareholders’ equity4,767.94,842.1
Total liabilities and shareholders' equity$ 10,809.1$ 11,017.3
Supplemental Disclosures of Balance Sheet Information  
Preferred shares, issued (in shares)0.00.0
Preferred shares, outstanding (in shares)0.00.0
Ordinary shares, issued (in shares)135.5134.7
Ordinary shares, outstanding (in shares)135.5134.7
PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women's health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada. This segment offers its products under Burt's Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands. Consumer Self-Care International segment comprises consumer self-care product categories outside the U.S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe. In addition, the company offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
 CEO
 WEBSITEperrigo.com
 INDUSTRYPharmaceuticals
 EMPLOYEES8900

Perrigo Co PLC Frequently Asked Questions


What is the ticker symbol for Perrigo Co PLC? What does PRGO stand for in stocks?

PRGO is the stock ticker symbol of Perrigo Co PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Perrigo Co PLC (PRGO)?

As of Thu Apr 18 2024, market cap of Perrigo Co PLC is 4.06 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRGO stock?

You can check PRGO's fair value in chart for subscribers.

What is the fair value of PRGO stock?

You can check PRGO's fair value in chart for subscribers. The fair value of Perrigo Co PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Perrigo Co PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PRGO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Perrigo Co PLC a good stock to buy?

The fair value guage provides a quick view whether PRGO is over valued or under valued. Whether Perrigo Co PLC is cheap or expensive depends on the assumptions which impact Perrigo Co PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRGO.

What is Perrigo Co PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, PRGO's PE ratio (Price to Earnings) is -319.48 and Price to Sales (PS) ratio is 0.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRGO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Perrigo Co PLC's stock?

In the past 10 years, Perrigo Co PLC has provided -0.137 (multiply by 100 for percentage) rate of return.